title: HMG-CoA reductase inhibition protects the diabetic myocardium from ischemia-reperfusion injury.
authors.affiliation: Department of Molecular and Cellular Physiology, LSU Health Sciences Center, Shreveport, Louisiana 71130, USA. dlefer@lsuhsc.edu
authors.forename: D J
authors.initials: DJ
authors.lastname: Lefer
authors.forename: R
authors.initials: R
authors.lastname: Scalia
authors.forename: S P
authors.initials: SP
authors.lastname: Jones
authors.forename: B R
authors.initials: BR
authors.lastname: Sharp
authors.forename: M R
authors.initials: MR
authors.lastname: Hoffmeyer
authors.forename: A R
authors.initials: AR
authors.lastname: Farvid
authors.forename: M F
authors.initials: MF
authors.lastname: Gibson
authors.forename: A M
authors.initials: AM
authors.lastname: Lefer
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D004730:Endothelium, Vascular / Q000201:enzymology; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008954:Models, Biological; D017202:Myocardial Ischemia / Q000150:complications*; D015428:Myocardial Reperfusion Injury / Q000188:drug therapy* / Q000209:etiology; D009336:Necrosis; D009504:Neutrophils / Q000187:drug effects; D017942:Nitric Acid / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000235:genetics / Q000378:metabolism; D052250:Nitric Oxide Synthase Type III; D012333:RNA, Messenger / Q000032:analysis; D019821:Simvastatin / Q000627:therapeutic use*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D012333:RNA, Messenger; D017942:Nitric Acid; D019821:Simvastatin; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III